
Reset all filters
01 6Cipralex/Lexapro
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 387
2019 Revenue in Millions : 376
Growth (%) : 3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 358
2020 Revenue in Millions : 381
Growth (%) : -1
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 340
2021 Revenue in Millions : 358
Growth (%) : -5
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 308
2022 Revenue in Millions : 340
Growth (%) : -10
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 284
2023 Revenue in Millions : 308
Growth (%) : -8
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 347
2018 Revenue in Millions : 339
Growth (%) : 3